文献
J-GLOBAL ID:201402247913793053
整理番号:14A0674988
先端巨大症におけるオクトレオチドに対するパシレオチド: 両者相対した優位性研究
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
著者 (28件):
COLAO A.
(Universita Federico II di Napoli, Naples, ITA)
,
COLAO A.
(Pasireotide C2305 Study Group)
,
BRONSTEIN M. D.
(Univ. of Sao Paulo Medical School, Sao Paulo, BRA)
,
BRONSTEIN M. D.
(Pasireotide C2305 Study Group)
,
FREDA P.
(Columbia Univ. Coll. of Physicians and Surgeons, New York)
,
FREDA P.
(Pasireotide C2305 Study Group)
,
GU F.
(Peking Union Medical Coll. Hospital, Chinese Acad. of Medical Sci., Beijing, CHN)
,
GU F.
(Pasireotide C2305 Study Group)
,
SHEN C.-C.
(Taichung Veterans General Hospital, Taichung, TWN)
,
SHEN C.-C.
(Hungkuang Univ., Taichung, TWN)
,
SHEN C.-C.
(Tri-Serv. General Hospital, National Defense Medical Center, Taipei, TWN)
,
SHEN C.-C.
(Pasireotide C2305 Study Group)
,
GADELHA M.
(Hospital Universitario Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BRA)
,
GADELHA M.
(Pasireotide C2305 Study Group)
,
FLESERIU M.
(Oregon Health and Sci. Univ., Oregon)
,
FLESERIU M.
(Pasireotide C2305 Study Group)
,
VAN DER LELY A. J.
(Erasmus Univ. Medical Center, Rotterdam, NLD)
,
VAN DER LELY A. J.
(Pasireotide C2305 Study Group)
,
FARRALL A. J.
(Univ. of Edinburgh, Edinburgh, GBR)
,
FARRALL A. J.
(Pasireotide C2305 Study Group)
,
RESENDIZ K. Hermosillo
(Novartis Pharmaceuticals Corp., Florham Park, New Jersey)
,
RESENDIZ K. Hermosillo
(Pasireotide C2305 Study Group)
,
RUFFIN M.
(Novartis Pharma AG, Basel, CHE)
,
RUFFIN M.
(Pasireotide C2305 Study Group)
,
CHEN Y.
(Novartis Pharmaceuticals Corp., Florham Park, New Jersey)
,
CHEN Y.
(Pasireotide C2305 Study Group)
,
SHEPPARD M.
(Univ. of Birmingham, Birmingham)
,
SHEPPARD M.
(Pasireotide C2305 Study Group)
資料名:
Journal of Clinical Endocrinology & Metabolism
(Journal of Clinical Endocrinology & Metabolism)
巻:
99
号:
3
ページ:
791-799
発行年:
2014年03月
JST資料番号:
B0517A
ISSN:
0021-972X
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)